Renaissance Capital logo

Tempus AI Priced, Nasdaq: TEM

Provides data and analytics tools for precision medicine.

Industry: Health Care

Latest Trade: $24.69 -0.62 (-2.4%)

First Day Return: +8.8%

Return from IPO: -31.6%

Industry: Health Care

We endeavor to unlock the true power of precision medicine by creating Intelligent Diagnostics through the practical application of artificial intelligence, or AI, in healthcare. Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal. We make tests intelligent by connecting laboratory results to a patient’s own clinical data, thereby personalizing the results. Our novel insight was realizing that all laboratory test results, genomic or otherwise, could be contextualized for a specific patient based upon that patient’s unique characteristics, and technology could therefore guide therapy selection and treatment decisions to allow each patient to progress on their own unique path. The drugs recommended, the clinical trials explored, the care pathways evaluated, the adverse events considered—all have the potential to be refined and enhanced when test results are connected to a patient’s personal profile, enabling the right patient to be routed to the right therapy at the right time. To accomplish this, we built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful.
more less
IPO Data
IPO File Date 05/20/2024
Offer Price $37.00
Price Range $35.00 - $37.00
Offer Shares (mm) 11.1
Deal Size ($mm) $411
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 06/13/2024
Offer Price $37.00
Price Range $35.00 - $37.00
Offer Shares (mm) 11.1
Deal Size ($mm) $411
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
Morgan Stanley
J.P. Morgan
more
Company Data
Headquarters Chicago, IL, United States
Founded 2015
Employees 2,300
Website www.tempus.com

Tempus AI (TEM) Performance